Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe screenshots show only minor visual differences and no changes to essential study details like eligibility, outcomes, enrollment status, or study locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference4%

- Check46 days agoChange DetectedVersion bump to v3.1.0 with removal of several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a reorganization or narrowing of content.SummaryDifference0.5%

- Check60 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The Back to Top element was removed; no substantive changes to core content, pricing, stock, or time-slot information.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check75 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as important topics related to drug safety and various diseases. Notably, previous mentions of specific ataxias and location details have been removed.SummaryDifference4%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.